Alaa Radhi Khudair (PhD Assitant prof. at the college of pharmacy/ university of Baghdad) Born in 1985 on Baghdad/ Iraq, Graduate from the College of Pharmacy / University of Baghdad 2007-2008, holds a Master degree in Pharmacology and Toxicology from the College of Pharmacy / University of Baghdad in 2015, Acceptance for a doctoral study at the College of Pharmacy / University of Baghdad, Department of Pharmacology and Toxicology for the year 2017-2018, holds the PhD degree in the Pharmacology and Toxicology from the College of Pharmacy / University of Baghdad in 2021.
holds the PhD degree in the Pharmacology and Toxicology from the College of Pharmacy / University of Baghdad in 2021.
PhD lecturer at the college of pharmacy/ university of Baghdad
PhD lecturer at the college of pharmacy/ university of Baghdad
Pharmacology and Toxicology
Pharmaceutical sciences
Pharmacology II Introduction to CNS pharmacology. CNS stimulants. Anxiolytic and Hypnotic drugs. General and Local Anesthetics.
drugs. Antipsychotic (neuroleptic) drugs. Opioid analgesics and antagonists. Treatment of neurodegenerative diseases. Antiepileptic Drugs. Diuretics. The treatment of heart failure (HF). Antiarrhythmic drugs. Antihypertensive drugs. Antianginal Drugs. Drugs affecting the blood. Antihyperlipidemic drugs. Gastrointestinal and antiemetic drugs. Drugs acting on the respiratory system.
Advanced pharmacology II master 2nd semester
clinical toxicology PhD students
Research Methodology Master and PhD
Advance systemic Toxicology II
Biotechnology PhD
هدى حميد رشيد ماجستير مريم سالم ارحيم عائشة مازن عبد اللطيف اسراء عبد الجبار
Background: Chemotherapeutic medication treatment for cancer is typically used in conjunction with other techniques as part of a routine regimen. It is well established that the capacity of different chemotherapeutic drugs to induce apoptosis is correlated with their anticancer efficacy. Quinazolinone-based drugs have demonstrated excellent responses from several cancer cell types. These substances have a lot of potential for use as building blocks in the creation of apoptosis inducers. Objective: To assess the new quinazolinone derivatives (M1 and M2) that were recently synthesized for their potential to halt wound healing and to use the acridine orange/propidium iodide (AO/PI) double stain to assess their capacity to induce apopto
... Show More
(4)
(1)
Abstract
Objectives: The present study designed to explore the genotoxicity through measurement of Mitotic index in bone marrow and the spleen cells, as possible mechanism of bone marrow and spleen toxicity that induced by irinotecan; and to describe the protective actions of omega 3 against irinotecan induced genotoxicity in bone marrow and the spleen of rats.
Methods: Twenty four (24) rats (Sprague-Dawley) were randomly divided into four groups: Group Ӏ, rats received single oral daily dose of distilled water (2 ml/kg) for 25 days (negative control group); Group ӀӀ (irinotecan-treated), receiv
... Show More
(7)
(2)
Ciprofloxacin, which is a second generation of fluoroquinolone and one of the most effective and widely used drugs within fluoroquinolone. Unfamiliar adverse effects of ciprofloxacin such as bone marrow (BM) suppression, thrombocytopenia, anemia, agranulocytosis, renal failure, and others observed. Lutein, is a xanthophyll (an oxygenated carotenoid), was focused by most studies as it has a strong antioxidant activity in vitro; and also, it has been associated with reducing the risk of the age-related disorders. The current study was designed to describe the role of apoptosis through the measurement of Bcl-2 associated X protein (Bax) marker, as mechanisms of bone marrow toxicity induced by ciprofloxacin and to find whether lutei
... Show More
(6)
(1)